A study assessing polyp formation in a dMMR mouse model showed that altering the gut microbiota via antibiotic administration significantly reduced early-stage colonic polyp numbers in MSH2-deficient mice, suggesting that these microbiota act at an early stage in the development of dMMR CRC [56]. The gene discussed is MSH2; the disease is colorectal carcinoma.